Cartesian Therapeutics, Inc. (RNAC) vs Whitehawk Therapeutics Inc (WHWK)
A side-by-side comparison of Cartesian Therapeutics, Inc. and Whitehawk Therapeutics Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
RNAC
Cartesian Therapeutics, Inc.
$6.91HealthcareDelayed quote: Oct 6, 2026, 3:20 PM EDT
WHWK
Whitehawk Therapeutics Inc
$3.59HealthcareDelayed quote: Oct 6, 2026, 3:13 PM EDT
Total return — RNAC vs WHWK
growth of $100 · dividends reinvested · last 9yRNAC -98.7% (-38.1%/yr)WHWK -95.9% (-29.9%/yr)WHWK compounded faster over this window
RNAC WHWK
RNAC vs WHWK: by the numbers
- •WHWK is the larger company ($204M vs $203M market cap).
- •Both run net losses; WHWK's is the smaller (-288.26% vs -10422.48% net margin).
Metrics side by side
Valuation
| Metric | RNAC | WHWK |
|---|---|---|
| P/S ratio | 137.46 | N/A |
| P/B ratio | N/A | 1.12 |
Profitability
| Metric | RNAC | WHWK |
|---|---|---|
| Gross margin | 100.00% | 89.36% |
| Operating margin | -3099.93% | -1601.12% |
| Net margin | -10422.48% | -288.26% |
| ROE | N/A | -43.64% |
| ROIC | -33.10% | -47.05% |
Growth (annualized)
| Metric | RNAC | WHWK |
|---|---|---|
| Revenue CAGR (5Y) | -50.01% | N/A |
| Total return CAGR (5Y) | -44.03% | -33.13% |
Frequently asked
- How have RNAC and WHWK total returns compared?
- Over the past 5 years, RNAC delivered -44.03% and WHWK delivered -33.13% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.